Kristin J. Lastwika, Ph.D.
Affiliations: | 2014 | Biomedical Sciences | The George Washington University, Washington, DC, United States |
Area:
Molecular Biology, Microbiology, SystematicGoogle:
"Kristin Lastwika"Parents
Sign in to add mentor| David Leitenberg | grad student | 2014 | The George Washington University | |
| (Regulation and Consequences of PD-L1 Expression in Non-Small Cell Lung Cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lastwika KJ, Kargl J, Zhang Y, et al. (2018) Tumor-Derived Autoantibodies Identify Malignant Pulmonary Nodules. American Journal of Respiratory and Critical Care Medicine |
| Lastwika KJ, Wilson W, Li QK, et al. (2015) Control of PD-L1 expression by oncogenic activation of the AKT/mTOR pathway in non-small cell lung cancer. Cancer Research |
| Robinson GL, Robinson JP, Lastwika KJ, et al. (2013) Akt signaling accelerates tumor recurrence following ras inhibition in the context of ink4a/arf loss. Genes & Cancer. 4: 476-85 |
| Lastwika K, Wilson W, Dennis PA. (2013) Abstract 4981: PI3K/AKT/mTOR pathway activation drives expression of the immune inhibitory ligand PD-L1 in NSCLC. Cancer Research. 73: 4981-4981 |
| Robinson JP, Vanbrocklin MW, Lastwika KJ, et al. (2011) Activated MEK cooperates with Ink4a/Arf loss or Akt activation to induce gliomas in vivo. Oncogene. 30: 1341-50 |